(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
Alcohol intake of more than two drinks per day is a risk factor for breast cancer
Megestrol Acetate
Antibody Therapy
Morphea
Docetaxel
Raloxifene
Advocacy
Cyclophosphamide
BRCA Gene
Hormone Replacement Therapy
ECOG Score
Mastectomy
Breast Cancer
Herceptin
Doxorubicin
5-Fluorouracil
Hormone Receptor Status
Phyllodes Tumor
Dose Dense Therapy
Biopsy
Multimodality Therapy
PARP Inhibitors
Absolute Risk
Down-Staging
Kappa Epsilon
CMF Chemotherapy
Estrogen/Estradiol
Cachexia
Neoadjuvant Therapy
Breast Tomosynthesis
Physical activity may reduce the risk of breast cancers
mTOR Inhibitors
Cytotoxic
EGFR
Ayurveda
Radiotherapy
Cyst
Ovarian Suppression
FISH
Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
Family History
Tumor Grade
Bilateral Prophylactic Mastectomy
Women ages 40+ should have a clinical breast exam at least yearly
Flow Cytometry
Lymphoscintigraphy
Immunotherapy
Mastodynia
Checkpoint Inhibitor
Oligometastases
Fibroadenoma
MRI
ER +/-
Triple +/- Breast Cancer
Breast cancer is the leading cause of death in women between the ages of 40 and 55
For every 1,000 screening mammograms performed, about five breast cancers are detected.
Aromatase Inhibitors
Antiemetics
Bevacizumab
HER-2
CDK4/6 Inhibitors
African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
Genetic Counseling
Co-survivor
Adenocarcinoma
BI-RADS
Palpation
In-situ Carcinoma
Tamoxifen
PI3 Kinase Inhibitors
Relapse
Ki-67 Rate
Multifocal Tumors
Paclitaxel
BOCA
Gene Mutation
Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
Chemotherapy
Cytostatic
Progestin
Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt